Submitted by Anonymous (not verified) on 19 May 2026 - 16:15
Human medicines European public assessment report (EPAR): Tecartus, brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 18, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tecartus, brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 18, Status: Authorised